on ABIVAX (EPA:ABVX)
JP Morgan Chase Reduces Stake in ABIVAX
On March 7, 2025, JP Morgan Chase & Co. announced that it had crossed the threshold of 5% of the capital of ABIVAX. This move took place on March 4, 2025, with a holding of 2,999,085 shares, representing 4.73% of the capital and 4.22% of the voting rights.
This change results from a reduction in shares held through assimilation. JP Morgan Securities LLC holds shares through contracts allowing for immediate use of the affected shares. In addition, cash-settled depository receipts and equity swaps are added to this complex holding structure.
These changes reflect JP Morgan's dynamic strategy regarding its stake in ABIVAX, while complying with French regulations regarding threshold crossing reporting.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news